After years of worrying that running or sneezing would leave me needing fresh underwear, a quick, minimally invasive procedure changed my life ...
Tenth Breakthrough Therapy Designation for Daiichi Sankyo and AstraZeneca’s ENHERTU with the latest based on DESTINY-Breast05 phase 3 trial results Sixteenth Breakthrough Therapy Designation granted ...
For patients undergoing salvage surgery or radiation, Kelly L. Stratton, MD, FACS, notes that previous focal therapy can influence outcomes. Among the sessions featured at the 2025 Society of Urologic ...
Introduction: Neurofeedback in the treatment of psychological disorders has gained increasingly widespread interest in recent years. As the use of neurofeedback training expands, it is important to ...
Subscribe Login Register Log out My Profile Subscriber Services Search EBLADE ENTER-TO-WIN BLADE REWARDS BLADE VAULT / REPRINTS OBITUARIES JOBS CLASSIFIEDS BLADE HOMES HOMES WEEKLY ADS EVENTS CONTACT ...
A study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that most of the benefits of androgen deprivation therapy (ADT) for prostate cancer occur within the first ...
Patients who received ADT for 3 months or 9 months had worse overall survival than those treated for 36 months. For men with prostate cancer treated with definitive radiotherapy, the benefit derived ...
This article originally appeared on Politifact. What does it mean when a warning label is removed from a medication after two decades? But the science wasn't so clear cut. The study that drove the ...
Prostate cancer recurrence after both radical prostatectomy and external beam radiotherapy (EBRT) has long been regarded as almost untreatable with curative intent. Most patients have traditionally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results